Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1998Transplantation

Immunosuppressive Effects and Safety of a Sirolimus/Cyclosporine Combination Regimen for Renal Transplantation1

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBarry D. KahanThe University of Texas Health Science Center at HoustonJPJeanette M. PodbielskiUniversity of Southern CaliforniaKNKimberly L. NapoliSt George's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kahan et al. (1998) studied this question.

synapsesocial.com/papers/6a7048d4abc331a85807978ahttps://doi.org/10.1097/00007890-199810270-00013
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1VARIABLE ORAL ABSORPTION OF CYCLOSPORINE1996 · 253 citations
  2. 2THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL TRANSPLANTATION1, 21992 · 46 citations
  3. 3Rapamycin Prolongs Survival and Arrests Pathophysiologic Changes in Murine Systemic Lupus Erythematosus1994 · 180 citations
  4. 4The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo1994 · 50 citations
  5. 5Pharmacokinetics of Sirolimus in Stable Renal Transplant Patients after Multiple Oral Dose Administration1997 · 218 citations